260 related articles for article (PubMed ID: 2819727)
21. Small cell lung cancer and topoisomerases.
Giaccone G
Anticancer Res; 1994; 14(1B):269-76. PubMed ID: 8166466
[TBL] [Abstract][Full Text] [Related]
22. Quinolones share a common interaction domain on topoisomerase II with other DNA cleavage-enhancing antineoplastic drugs.
Elsea SH; Westergaard M; Burden DA; Lomenick JP; Osheroff N
Biochemistry; 1997 Mar; 36(10):2919-24. PubMed ID: 9062121
[TBL] [Abstract][Full Text] [Related]
23. Binding of etoposide to topoisomerase II in the absence of DNA: decreased affinity as a mechanism of drug resistance.
Kingma PS; Burden DA; Osheroff N
Biochemistry; 1999 Mar; 38(12):3457-61. PubMed ID: 10090731
[TBL] [Abstract][Full Text] [Related]
24. DNA substrate specificity of reverse gyrase from extremely thermophilic archaebacteria.
Slesarev AI; Kozyavkin SA
J Biomol Struct Dyn; 1990 Feb; 7(4):935-42. PubMed ID: 2155623
[TBL] [Abstract][Full Text] [Related]
25. Eukaryotic DNA topoisomerase II beta.
Austin CA; Marsh KL
Bioessays; 1998 Mar; 20(3):215-26. PubMed ID: 9631649
[TBL] [Abstract][Full Text] [Related]
26. Expression and relationship between topoisomerase I and II alpha genes in tumor and normal tissues in esophageal, gastric and colon cancers.
Kim R; Ohi Y; Inoue H; Toge T
Anticancer Res; 1999; 19(6B):5393-8. PubMed ID: 10697567
[TBL] [Abstract][Full Text] [Related]
27. Molecular characterization of type II topoisomerase in the endosymbiont-bearing Trypanosomatid Blastocrithidia culicis.
Lourenço EE; Cavalcanti DP; Assine Picchi GF; Souza W; Aurélio Krieger M; Machado Motta MC; Goldenberg S; Perdigão Fragoso S
FEMS Microbiol Lett; 2006 Apr; 257(1):163-70. PubMed ID: 16553848
[TBL] [Abstract][Full Text] [Related]
28. New mechanistic and functional insights into DNA topoisomerases.
Chen SH; Chan NL; Hsieh TS
Annu Rev Biochem; 2013; 82():139-70. PubMed ID: 23495937
[TBL] [Abstract][Full Text] [Related]
29. DNA topoisomerase II as a potential factor in drug resistance of human malignancies.
Potmesil M; Hsiang YH; Liu LF; Wu HY; Traganos F; Bank B; Silber R
NCI Monogr; 1987; (4):105-9. PubMed ID: 3041236
[TBL] [Abstract][Full Text] [Related]
30. Topoisomerases in human disease.
Epstein RJ
Lancet; 1988 Mar; 1(8584):521-4. PubMed ID: 2893929
[TBL] [Abstract][Full Text] [Related]
31. The unique DNA topology and DNA topoisomerases of hyperthermophilic archaea.
Forterre P; Bergerat A; Lopez-Garcia P
FEMS Microbiol Rev; 1996 May; 18(2-3):237-48. PubMed ID: 8639331
[TBL] [Abstract][Full Text] [Related]
32. DNA topoisomerases as targets for anticancer drugs.
Topcu Z
J Clin Pharm Ther; 2001 Dec; 26(6):405-16. PubMed ID: 11722677
[TBL] [Abstract][Full Text] [Related]
33. Exploring DNA topoisomerases as targets of novel therapeutic agents in the treatment of infectious diseases.
Tse-Dinh YC
Infect Disord Drug Targets; 2007 Mar; 7(1):3-9. PubMed ID: 17346206
[TBL] [Abstract][Full Text] [Related]
34. DNA topoisomerases--new twists to tumour therapy.
Lancet; 1988 Mar; 1(8584):512-3. PubMed ID: 2893923
[No Abstract] [Full Text] [Related]
35. DNA topoisomerases from Streptomyces noursei: influence of coumarins and quinolones on the enzymic activity.
Störl K; Störl J; Roth M; Zimmer C
Biochim Biophys Acta; 1994 Mar; 1199(2):143-8. PubMed ID: 8123663
[TBL] [Abstract][Full Text] [Related]
36. Reverse gyrase: a helicase-like domain and a type I topoisomerase in the same polypeptide.
Confalonieri F; Elie C; Nadal M; de La Tour C; Forterre P; Duguet M
Proc Natl Acad Sci U S A; 1993 May; 90(10):4753-7. PubMed ID: 8389456
[TBL] [Abstract][Full Text] [Related]
37. Studies on DNA polymerases and topoisomerases in archaebacteria.
Forterre P; Elie C; Sioud M; Hamal A
Can J Microbiol; 1989 Jan; 35(1):228-33. PubMed ID: 2541877
[TBL] [Abstract][Full Text] [Related]
38. Yeast systems for demonstrating the targets of anti-topoisomerase II agents.
Nitiss JL; Nitiss KC
Methods Mol Biol; 2001; 95():315-27. PubMed ID: 11089243
[No Abstract] [Full Text] [Related]
39. The response of eukaryotic topoisomerases to DNA damage.
Kingma PS; Osheroff N
Biochim Biophys Acta; 1998 Oct; 1400(1-3):223-32. PubMed ID: 9748592
[TBL] [Abstract][Full Text] [Related]
40. Topoisomerase Inhibitors and Targeted Delivery in Cancer Therapy.
You F; Gao C
Curr Top Med Chem; 2019; 19(9):713-729. PubMed ID: 30931860
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]